Penjualan Perubahan Tanggal
Agenus USD 33.7M 500K 2026-03
Amgen USD 10.4B 300M 2026-09
Anika Therapeutics USD 30.62M 2.8M 2025-12
Arrowhead Research USD 450.82M 375.59M 2026-09
AstraZeneca USD 16.21B 830M 2026-09
BioMarin Pharmaceutical USD 1.03B 40M 2026-09
Bristol-Myers Squibb USD 13.07B 100M 2026-09
Celldex Therapeutics USD 400K 378K 2026-09
Daiichi Sankyo JPY 592.49B 17.75B 2026-09
Eli Lilly USD 24.4B 1.43B 2026-09
Halozyme Therapeutics USD 492.97M 11.97M 2026-09
Heron Therapeutics USD 40.59M 2.38M 2025-12
Intrexon USD 717K 511K 2024-06
Ionis Pharmaceuticals USD 243M 25M 2026-09
Karyopharm Therapeutics USD 35.07M 987K 2026-03
Ligand Pharmaceuticals USD 78.75M 4.95M 2026-09
MacroGenics USD 32.83M 12.03M 2026-06
Neurocrine Biosciences USD 1.12B 161M 2026-09
Pfizer USD 16.6B 1.57B 2026-09
Regeneron Pharmaceuticals USD 5.12B 830M 2026-09
Rigel Pharmaceuticals USD 55.31M 18.47M 2024-09
Sangamo BioSciences USD 356K 125K 2024-06
Ultragenyx Pharmaceutical USD 173M 41M 2026-09
Veracyte USD 151.75M 1.43M 2026-09